Catheters are used in a number of processes, such as: cardiovascular,
urological, intravenous, oximetry, thermodilution, suction and wound drainage
processes, that involve the administration or drainage of fluids from the
body. The global market for catheters is vibrant and continually evolving with
significant investments to improve the capabilities of existing catheters,
improve safety features and identify new medical applications. The growing
number of aged people undergoing diagnostic and therapeutic procedures is
driving increases in catheter sales. Government regulations also play a key
role, mainly in the urological catheter segment, as regulations attempt to
promote fewer infections among hospitalized patients through more frequent use
of catheterization. This TriMark Publications report provides a detailed
analysis of the global market for catheters, including central venous
catheters (CVC), peripheral venous catheters (PVC), midline catheters (MC),
hemodialysis catheters, pulmonary artery catheters, peripheral artery
catheters and umbilical catheters. The study also analyzes almost all of the
companies known to be marketing, manufacturing or developing catheter products
in the U.S. and worldwide. Detailed tables, charts and figures are included
with projected sales data by geographic region for the Americas, EMRA (Europe,
the Middle East, Russia, Africa) and Asia-Pacific regions.
Methodology
The author of this report is a retired college professor with more than 30
years of experience in teaching biochemistry - biochemical pharmacology,
biotechnology and molecular biology. He also has four years of experience in
editing market research reports on healthcare topics. Company-specific
information for this report has been obtained mainly from industry trade
publications, academic journals, news and research articles, press releases
and corporate websites, as well as annual reports for publicly-held firms.
Additionally, sources of information include the non-governmental
organizations (NGOs) such as the World Health Organization (WHO) and
governmental entities like the U.S. Department of Health and Human Services
(FIRS) and U.S. federal agencies such as the National Institutes of Health
(NIH), the Food and Drug Administration (FDA) and the Centers for Disease
Control and Prevention (CDC). Where possible and practicable, the most recent
data available have been used.
Some of the statistical information was taken from Biotechnology Associates'
databases and from TriMark's private data stores. The information in this
study was obtained from sources that we believe to be reliable, but we do not
guarantee the accuracy, adequacy or completeness of any information or
omission or for the results obtained by the use of such information. Key
information from the business literature was used as a basis to conduct
dialogue with and obtain expert opinion from market professionals regarding
commercial potential and market sizes. Senior managers from major company
players were interviewed for part of the information in this report.
Primary Sources
TriMark collects information from hundreds of Database Tables and many
comprehensive multi-client research projects, as well as Sector Snapshots that
we publish annually. We extract relevant data and analytics from TriMark' s
research as part of this data collection.
Secondary Sources
TriMark uses research publications, journals, magazines, newspapers,
newsletters, industry reports, investment research reports, trade and industry
association reports, government-affiliated trade releases and other published
information as part of its secondary research materials. The information is
then analyzed and translated by the Industry Research Group into a TriMark
study. The Editorial Group reviews the complete package with product and
market forecasts, critical industry trends, threats and opportunities,
competitive strategies and market share determinations.
Table of Contents
Table of Contents
1. Introduction
1.1. Scope of this Report
1.2. Methodology
1.3. Executive Summary
2. Catheter Uses and Types
2.1. Scope of this Chapter
2.2. Catheter Uses
2.3. Types of Catheters
2.3.1. Cardiovascular Catheters
2.3.1.1. Cardiac Catheterization Procedures
2.3.1.2. Indications for Cardiac Catheterization
2.3.2. Percutaneous Coranary Intervention (PCI)
2.3.3. Athrectomy
2.3.4. Ventricular Angiogram
2.3.5. Coronary Flow Reserve Measurements
2.3.6. Intravascular Ultrasound Imaging
2.3.7. Pericardiocentesis
2.3.8. Heart Biopsy Catheters
2.3.9. Atrial Fibrillation Catheters
2.3.10. Ablation Electrophysiology Catheters
2.3.10.1. New Cardiac Ablation Technology Trends
2.3.10.2. Next Generation Atrial Fibrillation Ablation Catheters
2.4. Urological Applications of Catheters
2.4.1. Condom Catheters
2.4.2. Indwelling Urethral Catheters
2.4.3. Intermittent Catheters
2.4.4. Dialysis Catheters
2.4.4.1. Advances in Urinary Catheter Technology
2.4.4.2. Biocompatibility
2.4.4.3. Biofilms and Encrustation
2.4.4.4. Issues in Intermittent Self-Catheterization
2.4.4.5. Coatings for Urinary Catheters
2.5. Neurovascular Applications of Catheters
2.6. Venous Access Applications of Catheters
2.6.1. Central Venous Catheters (CVC)
2.6.2. Short Peripheral Inserted Catheters (PIC)
2.6.3. Midline Catheters (MC)
2.6.4. Peripherally Inserted Central Catheter (PICC)
2.6.5. Pulmonary Artery Catheters (PAC)
2.6.6. Tunneled Central Catheters
2.6.7. Implanted Ports for Central Catheters
2.7. Oximetric Catheter
2.8. Thermodilution Catheters
2.9. Suction Catheters
2.10. Wound Drainage Catheters
2.11. Umbilical Catheters
2.12. Catheter Coating
2.13. Comparison of Three Common Catheter Materials
2.13.1. Silicones
2.13.2. Polyvinyl Chloride
2.13.3. Latex Rubber
2.14. Comparison of Silicone, PVC and Latex
2.15. The Making of Catheters
2.15.1. History
2.15.2. Raw Materials and Design
3. Disease Conditions that Fuel the Growth of Catheter Market
3.1. Scope of this Chapter
3.1. Cardiovascular Diseases
3.1.1. Mortality from Heart Disease and Stroke in Selected OECD Countries
3.1.2. Market for Cardiovascular Devices
3.1.3. Market Leaders in Cardiovascular Devices
3.2. Catheters and Ports in Cancer Treatment
3.2.1. Cancer in the U.S.
3.2.2. Mortality from Cancer in OECD Countries
3.2.3. Global Oncology Market
3.3. Renal Failure
3.3.2. Renal Failure in OECD Countries
3.3.3. Global Dialysis Market
3.3.4. Number of Dialysis Patients Globally
3.3.5. Number of U.S. Dialysis Patients
3.3.6. U.S. Dialysis Market
3.3.7. U.S. Dialysis Procedures by Segment
4. Trends in Overall Medical Device Industry
4.1. Scope of this Chapter
4.1.1. Global Medical Device Market
4.1.2. Market for Medical Devices in Americas
4.1.3. Medical Device Market in Western Europe
4.1.4. Medical Device Market in Central and Eastern Europe
4.1.5. Medical Device Market in Asia/Pacific
4.1.6. Medical Device Market in Middle East/Africa
4.1.7. Medical Device Market in China and India
5. Catheter Market: Overview
5.1. Scope of this Chapter
5.2. Segmentation of Catheter market
5.2.1. Global Market for Catheters
5.2.2. Market for Catheters in Americas
5.2.3. Catheter Market in Europe, Middle East, Russia and Africa,
2011-2018
5.2.4. Asia/Pacific Market for Catheters
5.2.5. Catheter Market in Japan
5.2.6. Global Catheter Market by Region
5.2.7. Global Catheter Market by Disease Segment
5.3. Market for Cardiovascular Catheters
5.3.1. Global Market for Diagnostic Catheters by Type
5.3.2. Global Market for Balloon Catheters
5.3.3. The Rise of Balloon Catheters in the U.S.
5.3.4. Fast Changing DEBs Market
5.3.5. Global Market for Electrophysiology Ablation Catheters
5.3.6. North American Market for Electrophysiology Ablation Catheters
5.3.7. European Market for Electrophysiology Ablation Catheters
5.3.8. Asia/Pacific Market for Electrophysiology Ablation Catheters
5.3.9. Single-Use Cardiac Catheter market
5.3.9.1. Global Market for Single-Use Catheters in Conventional
Diagnostics
5.3.9.2. Global Market for Single-Use Catheters Used in Standard
Ablation
5.3.9.3. Global Market for Single-Use Catheters Used in Advanced
Diagnostics
5.3.9.4. Global Market for SUD Catheters Used in Irrigated Ablation
5.4. Global Market for Urological Catheters
5.4.1. FDA-Approved Urological Catheters
5.4.2. U.S. Urology Devices Market
5.4.3. U.S. Intermittent Catheters Market
5.4.4. Market Leaders in Intermittent Catheters
5.4.5. Market Leaders in Foley Catheters
5.4.6. U.S. Market for Urinary Incontinence Products by Type
5.4.7. U.S. Urinary Incontinence Market by Segment
5.4.8. Market Leaders in Male External Catheters
5.5. Global Market for Central Venous Catheters
5.5.1. Global Central Venous Catheter (CVC) Market by Region
5.5.2. Market Leaders in Central Venous Catheter Market
5.5.3. Market Leaders in Implantable Catheter Ports
6. Global Market for Tissue Ablation Devices
6.1. Scope of this Chapter
6.1.1. Share of the Ablation Technologies by Clinical Specialty
6.1.2. Global Ablation Devices Market by Type
6.1.3. Electrical and Electrocautery Devices
6.1.4. Radiation Devices
6.1.5. Light-Based Ablation Devices
6.1.6. Radiofrequency (RF) Energy
6.1.7. Market Leaders in RF Ablation Devices
6.1.8. Ultrasound Energy
6.1.9. Cryotherapy
6.1.10. Thermal Ablation
6.1.11. Microwave Hyperthermia
6.1.12. Hydromechanical Ablation
6.2. U.S. Market for Tissue Ablation Devices
6.2.1. Cryoablation in the U.S.
6.2.2. Hydromechanical Ablation Therapy in the U.S.
6.2.3. `Ultrasound Tissue Ablation in the U.S.
6.2.4. Radiofrequency Ablation Therapy in the U.S.
6.2.5. Market for Tissue Ablation Devices in Asia/Pacific
6.2.5.1. Market for Tissue Ablation Devices in Japan
6.2.5.2. Chinese Market for Tissue Ablation Devices
6.2.5.3. Australian Market for Tissue Ablation Devices
6.2.5.4. Market for Tissue Ablation in India
6.3. Share of the Ablation Technologies by Clinical Specialty
6.3.1. Cancer Ablation Market by Type of Cancer
6.3.2. Global Ablation Technologies Market by Modality
7. Free Standing Diagnostic Cath Lab Market in the U.S.
7.1. Reimbursement Trends
7.2. Joint Venture Options
7.3. Payer Mix and Volume
7.4. Overhead Expenses
7.5. Space Requirements and Costs
7.6. Personnel Staffing
7.7. Credentialing Requirements and Responsible Oversight
7.8. Considering Structural Alternatives
8. Coding and Payment Information for Catheters, 2012
8.1. Medicare Coverage Policy
8.2. Private Insurance Coverage
8.3. Documentation
8.4. Codes and Payments for Hospitals for Procedures Performed in
Outpatient Setting
8.4.1. Codes and Payments for Inpatient Procedures
8.4.2. Codes and Payments for ASC Outpatient Procedures
8.5. Physician Payments
8.5.1. Physician Payment for Procedures Performed at a Facility
8.5.2. Physician Payment Performed in a Non-Facility Setting
